Clinical Trial Update: Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating the safety and efficacy of allogeneic umbilical cord mesenchymal stem cell therapy in patients with diabetic nephropathy i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy

Snippet

Sponsor: PT. Prodia Stem Cell Indonesia | Conditions: Diabetic Nephropathy Type 2 | Phase 1, Phase 2 | Status: RECRUITING